Neurocrine Biosciences Inc (STU:NB3)
€ 153.15 -1.9 (-1.23%) Market Cap: 15.37 Bil Enterprise Value: 14.57 Bil PE Ratio: 26.83 PB Ratio: 5.14 GF Score: 93/100

Neurocrine Biosciences, Inc at Goldman Sachs Healthcare Conference Transcript

Jun 9, 2026 / 01:20 PM GMT
Release Date Price: €143.25 (+1.31%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

NBIX.OQ - Neurocrine Biosciences, Inc
Neurocrine Biosciences, Inc at Goldman Sachs Healthcare Conference
Jun 09, 2026 / 01:20PM GMT

=====================
Conference Call Participants
=====================
* Corinne Johnson
Goldman Sachs Group Inc - Analyst

=====================
Presentation
--------------------------------------------------------------------------------
Corinne Johnson, Goldman Sachs Group Inc - Analyst [1]
--------------------------------------------------------------------------------
Welcome to the Goldman Sachs. You don't have any questions, yes.

=====================
Questions and Answers
--------------------------------------------------------------------------------
Corinne Johnson, Goldman Sachs Group Inc - Analyst [1]
--------------------------------------------------------------------------------
Very good. Well, thanks, everyone, for joining us here. We're thrilled to have the team from Neurocrine and Adam Green in the audience for our conversation
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot